About HeartWare
HeartWare is a company based in Framingham (United States) founded in 2005 was acquired by Medtronic in June 2016. HeartWare has raised $12.38 million across 3 funding rounds from investors including Medtronic. The company has 547 employees as of December 31, 2015. HeartWare has completed 2 acquisitions, including CircuLite and World Heart Corporation. HeartWare operates in a competitive market with competitors including Sequana Medical, CVRx, Element Science, Ancora Heart and SynCardia, among others.
- Headquarter Framingham, United States
- Employees 547 as on 31 Dec, 2015
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Heartware, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.38 M (USD)
in 3 rounds
-
Latest Funding Round
$220 K (USD), Post-IPO
Sep 25, 2009
- Investors
-
Employee Count
547
as on Dec 31, 2015
-
Investments & Acquisitions
CircuLite
& 1 more
-
Acquired by
Medtronic
(Jun 27, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of HeartWare
Unlock access to complete
Funding Insights of HeartWare
HeartWare has successfully raised a total of $12.38M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $220 thousand completed in September 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HeartWare
HeartWare has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medtronic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical equipment for treating over 30 chronic diseases is developed.
|
Locked | Locked | Locked |
Investor details for HeartWare
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HeartWare
HeartWare has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CircuLite and World Heart Corporation.
Investment portfolio details for HeartWare
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cardiac implants are developed for early-stage heart failure patients.
|
Locked | Locked | 2004 | Locked | |
|
Ventricular assist devices for heart failure patients are developed.
|
Locked | Locked | 1996 | Locked |
Complete acquisition details for HeartWare
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - HeartWare
Detailed financials for HeartWare
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Heartware Comparisons
Peer comparison for HeartWare
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HeartWare
HeartWare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, CVRx, Element Science, Ancora Heart and SynCardia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Implantable technology for hypertension and heart failure is developed.
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
|
| Locked | Locked | Locked |
Total artificial hearts are developed for cardiac replacement therapy.
|
Detailed competitors of HeartWare
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Heartware
Complete news archive for HeartWare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HeartWare
HeartWare was founded in 2005 and raised its 1st funding round 2 years after it was founded.
HeartWare is headquartered in Framingham, United States. It is registered at Framingham, Massachusetts, United States.
HeartWare is a funded company, having raised a total of $12.38M across 3 funding rounds to date.
As of Dec 31, 2015, the latest employee count at HeartWare is 547.
HeartWare was founded in 2005 in Framingham, United States, as a medical device company specializing in ventricular assist devices (VADs) for advanced heart failure patients. FDA approval was granted in 2012 for bridge-to-transplant therapy, while commercial availability has been established in Europe and Australia since 2009. Over 9,000 patients have been treated with the HeartWare Ventricular Assist System to date.
HeartWare's top competitors include Sequana Medical, CVRx and Adona Medical.
HeartWare has made 2 acquisitions, including CircuLite, and World Heart Corporation.
HeartWare has 1 investor. Key investors include Medtronic.